AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 87 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $113,000 | -55.9% | 48,918 | -9.3% | 0.00% | – |
| Q4 2021 | $256,000 | -40.5% | 53,918 | -0.4% | 0.00% | -100.0% |
| Q3 2021 | $430,000 | +17.2% | 54,143 | +2.8% | 0.00% | – |
| Q2 2021 | $367,000 | 0.0% | 52,667 | +13.7% | 0.00% | – |
| Q1 2021 | $367,000 | -6.1% | 46,332 | -6.8% | 0.00% | -100.0% |
| Q4 2020 | $391,000 | +21.8% | 49,702 | +9.7% | 0.00% | 0.0% |
| Q3 2020 | $321,000 | -32.7% | 45,327 | -12.0% | 0.00% | 0.0% |
| Q2 2020 | $477,000 | +169.5% | 51,527 | +35.8% | 0.00% | – |
| Q1 2020 | $177,000 | -38.1% | 37,952 | +1.3% | 0.00% | – |
| Q4 2019 | $286,000 | -0.3% | 37,482 | +0.5% | 0.00% | -100.0% |
| Q3 2019 | $287,000 | +22.1% | 37,311 | +8.5% | 0.00% | – |
| Q2 2019 | $235,000 | +21.1% | 34,378 | +42.5% | 0.00% | – |
| Q1 2019 | $194,000 | +19.8% | 24,130 | +11.9% | 0.00% | – |
| Q4 2018 | $162,000 | +16.5% | 21,571 | +48.7% | 0.00% | – |
| Q3 2018 | $139,000 | -13.7% | 14,502 | -4.8% | 0.00% | – |
| Q2 2018 | $161,000 | – | 15,233 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |